The extreme GGT activity ranges were not observed in the diseases with the largest patient populations tested (Table 1), such as lung cancers (10,930 cases), coronary heart disease (22,117 cases), type 2 diabetes (11,629 cases), and the healthy control (132,357). The gene discussed is GGT1; the disease is lung carcinoma.